Mesh infection in ventral incisional hernia repair: Incidence, contributing factors, and treatment

Surgical Infections

Volumn 12, Issue 3, 2011, Pages 205-210

  Sanchez, Vivian M ^a   Abi Haidar, Youmna E ^a   Itani, Kamal M F ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; LYSOSTAPHIN; POLITEF; SILVER;

ABDOMINAL AORTA ANEURYSM; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; ENTEROCUTANEOUS FISTULA; HERNIOPLASTY; INCIDENCE; INCISION; INCISIONAL HERNIA; INFECTION COMPLICATION; INTESTINE SURGERY; MESH INFECTION; OPERATION DURATION; PRIORITY JOURNAL; RISK FACTOR; SALVAGE THERAPY; SILVER IMPREGNATION; SURGICAL INFECTION; SURGICAL SITE INFECTION; VENTRAL INCISIONAL HERNIA REPAIR;

HERNIA, ABDOMINAL; HUMANS; INCIDENCE; RISK FACTORS; SURGICAL MESH; SURGICAL WOUND INFECTION;

EID: 80052771949     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2011.033     Document Type: Conference Paper

References (52)

1. Robinson TN, Clarke JH, Schoen J, et al. Major mesh-related complications following hernia repair. Surg Endosc 2005;19: 1556-1560.
2. Carlson MA, Frantzides CT, Shostrom VK, et al. Minimally invasive ventral herniorrhaphy: An analysis of 6,266 published cases. Hernia 2008;12:9-22.
3. Mangram A, Horan TC, Pearson ML, et al. Guidelines for prevention of surgical site infection. Am J Infect Control 1999;27:97-132.
4. Collage RD, Rosengart MR. Abdominal wall infections with in situ mesh. Surg Infect 2010;11:299-305.
5. Cobb WS, Carbonell AM, Kalbaugh CL, et al. Infection risk of open placement of intraperitoneal composite mesh. Am Surg 2009;75:762-768.
6. Vix J, Meyer C, Rohr S, et al. The treatment of incisional and abdominal hernia with a prosthesis in potentially infected tissues: A series of 47 cases. Hernia 1997;1:157-161.
7. Petersen S, Henke G, Freitag M, et al. Deep prosthesis infection in incisional hernia repair: Predictive factors and clinical outcome. Eur J Surg 2001;167:453-457.
8. Eriksen JR, Gogenur T, Rosenberg J. Choice of mesh for laparoscopic ventral hernia repair. Hernia 2007;11:481-492.
9. Korenkov M, Paul A, Sauerland S, et al. Classification and surgical treatment of incisional hernia: Results of an experts' meeting. Langenbecks Arch Surg 2001;386:65-73.
10. Hawn MT, Snyder CW, Graham LA et al. Long-term followup of technical outcomes for incisional hernia repair. J Am Coll Surg 2010; 210:648-657.
11. Jezupovs A, Mihelsons M. The analysis of infection after polypropylene mesh repairs of abdominal wall hernia. World J Surg 2006;30:2270-2278
12. Deysine M. Pathophysiology, prevention, and management of prosthetic infections in hernia surgery. Surg Clin North Am 1998;78:1105-1115.
13. Hawn MT, Gray SH, Snyder CW, et al. Predictors of mesh explantation following incisional hernia repair. J Am Coll Surg (in press).
14. Woodward J, Wright A. Aspergillus infection of abdominal wall biologic mesh. Surg Infect 2010;11:405-406.
15. Halaweish I, Harth K, Broome AM, et al. Novel in vitro model for assessing susceptibility of synthetic hernia repair meshes to Staphylococcus aureus infection using green fluorescent protein-labeled bacteria and modern imaging techniques. Surg Infect 2010;11:449-454.
16. Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis 2001;7:277-281.
17. Miller G. Promising agent emerging to battle mesh infections. Gen Surg News 2010;37(6):1, 16-17.
18. Stremitzer S, Bachleitner-Hofmann T, Gradl B, et al.Mesh graft infection following abdominal hernia repair: Risk factor evaluation and strategies of mesh graft preservation. A retrospective analysis of 476 operations. World J Surg 2010; 34:1702-1709.
19. Dunne JR, Malone DL, Tracy JK. Abdominal wall hernias: Risk factors for infection and resource utilization. J Surg Res 2003;111:78-84.
20. Finan KR, Vick CC, Kiefe CI, et al. Predictors of wound infection in ventral hernia repair. Am J Surg 2005;190: 676-681.
21. Kaafarani HM, Kaufman D, Reda D, et al. Predictors of surgical site infection in laparoscopic and open ventral incisional herniorrhaphy. J Surg Res 2010;16:229-234.
22. Houck JP, Rypins EB, Sarfeh IJ. Repair of incisional hernia. Surg Gynecol Obstet 1989;169:397-399.
23. Morriss-Stiff GJ, Hughes LE. The outcomes of nonabsorbable mesh placed within the abdominal cavity: Literature review and clinical experience. J Am Coll Surg 1998;186:352-367.
24. Luijendijk RW, Hop WCJ, van den Tol P, et al. A comparison of suture repair with mesh repair for incisional hernia. N Engl J Med 2000;343:392-398.
25. Kelly ME, Behrman SW. The safety and efficacy of prosthetic hernia repair in clean-contaminated and contaminated wounds. Am Surg 2002;68:524-529.
26. Merritt K, Hitchins VM, Neale AR. Tissue colonization from implantable biomaterials with low numbers of bacteria. J Biomed Mater Res 1999;44:261-265.
27. Klinge U, Junge K, Spellerberg B, et al. Do multifilament alloplastic meshes increase the infection rate? Analysis of the polymeric surface, the bacteria adherence, and the in vivo consequences in a rat model. J Biomed Mater Res 2002;63: 765-771.
28. Amid PK. Classification of biomaterials and their related complications in abdominal wall hernia surgery. Hernia 1997;1:15-21.
29. Petersen S, Henke G, Zimmermann L, et al. Ventral rectus fascia closure on top of mesh hernia repair in the sublay technique. Plast Reconstr Surg 2004;114:1754-1760.
30. Kaafarani HM, Hur K, Hirter A, et al. Seroma in ventral incisional herniorrhaphy: Incidence, predictors and outcome. Am J Surg 2009;198:639-644.
31. LeBlanc KA. Laparoscopic incisional and ventral hernia repair: Complications-how to avoid and handle. Hernia 2004;8:323-331.
32. Heniford BT, Park A, Ramshaw BJ, et al. Laparoscopic ventral and incisional hernia repair in 407 patients. J Am Coll Surg 2000;190:645-650.
33. Greenberg JJ. Can infected composite mesh be salvaged? Hernia 2010;14:589-592.
34. Paton BL, Novitsky YW, Zerey M, et al. Management of infections of polytetrafluoroethylene-based mesh. Surg Infect 2007;8:337-341.
35. Szczerba SR, Dumanian GA. Definitive surgical treatment of infected or exposed ventral hernia mesh. Ann Surg 2003;237: 437-441.
36. Aguilar B, Chapital AB, Madura JA II, et al. Conservative management of mesh-site infection in hernia repair. J Laparoendosc Adv Surg 2010;20:249-252.
37. Trunzo JA, Ponsky JL, Williams CP, et al. A novel approach for salvaging infected prosthetic mesh after ventral hernia repair. Hernia 2009;13:545-549.
38. Surgical Care Improvement Project (SCIP) Module 1: Infection Prevention. Medscape General Surgery 2006. Available at http://cme.medscape.com/viewarticle/ 531895-2
39. Carlson MA, Frantzides CT, Shostrom VK, et al. Minimally invasive ventral herniorrhaphy: An analysis of 6,266 published cases. Hernia 2008;12:9-22.
40. Breuing K, Butler CE, Ferzoco S, et al. Incisional ventral hernias: Review of the literature and recommendations regarding the grading and technique of repair. Surgery 2010; 148:544-558.
41. Rios A, Rodriguez JM, Munitiz V, et al. Antibiotic prophylaxis in incisional hernia repair using a prosthesis. Hernia 2001;5:148-152.
42. Abramov D, Jeroukhimov I, Yinnon AM, et al. Antibiotic prophylaxis in umbilical and incisional hernia repair: A prospective randomized study. Eur J Surg 1996;162:945-948.
43. Edwards C, Angstadt J, Whipple O, et al. Laparoscopic ventral hernia repair: Postoperative antibiotics decrease incidence of seroma related cellulitis. Am Surg 2005;71: 931-936.
44. Sanchez-Manuel FJ, Lozano-Garcia J, Seco-Gil JL. Antibiotic prophylaxis for hernia repair. Cochrane Database Syst Rev 2007;(3):CD003769.
45. Aufenacker TJ, Koelemay MJW, Gouma DJ, et al. Systematic review and meta-analysis of the effectiveness of antibiotic prophylaxis in prevention of wound infection after mesh repair of abdominal wall hernia. Br J Surg 2006;93:5-10.
46. Kollef MH, Barie PS. Methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization predicts intensive care unitacquired MRSA infections: True or false? Surg Infect 2010; 11:497-499.
47. Carbonell AM, Kercher KW, Sing RF, et al. Susceptibility of prosthetic biomaterials to infection. Surg Endosc 2006;20: 174-175.
48. Harrell AG, Novitsky YW, Kercher KW, et al. In vitro infectability of prosthetic mesh by methicillin-resistant Staphylococcus aureus. Hernia 2006;10:120-124.
49. Penttinen R, Gronroos JM. Mesh repair of common abdominal hernias: A review on experimental and clinical studies. Hernia 2008;12:337-344.
50. Awad SS, Rao RK, Berger DH, et al. Microbiology of infected acellular dermal matrix (AlloDerm) in patients receiving complex abdominal closure after emergency surgery. Surg Infect 2009;10:79-84.
51. Rosen MJ. Biologic mesh for abdominal wall reconstruction: A critical appraisal. Am Surg 2010;76:1-6.
52. Itani KMF, Awad SS, Baumann DD, et al. Prospective clinical study: Evidence of safe, single stage repair of infected/ contaminated abdominal incisional hernias using Strattice reconstructive tissue matrix. Hernia 2009;13(supp 1):S28.